We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





MEDLAB Middle East 2021 Brings World of Laboratory Medicine Together Under ‘United by Business’ Show Theme

By LabMedica International staff writers
Posted on 21 Jun 2021
Print article
Illustration
Illustration
The 2021 edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, took place at the Dubai World Trade Centre from 21-24 June, bringing the global healthcare community together under the show theme of ‘United by Business’.

A host of countries, including the UK, Germany, Austria, Belgium, Israel, Korea, Poland, Spain and the US, participated in the event. A range of key laboratory and trade professionals from across the region attended the live and in-person event. It featured a range of keynote speeches and scientific lectures, industry briefings, product demonstrations and networking opportunities, as well as a series of pre-arranged one-to-one meetings, with an emphasis on creating lasting relationships.

Underscoring the confidence within the industry and the increased demand from laboratory professionals to participate in a physical event, several companies and health authorities exhibited at the event. These included the UAE Ministry for Health and Prevention, the College of American Pathologists, Abbott Laboratories, Horiba, Randox Laboratories, Euroimmun, BioVender Group, Seegene, Stago and Erba Group.

Similar to last year, before travel restrictions and country-wide lockdowns, the event attracted over 23,000 professional visitors from over 140 countries and over 3,800 delegates. A total of 14 country pavilions were present at the 2021 edition of the show. The event featured eight Continuing Medical Education (CME) conferences during the live and in-person event and as part of the show's online element. New to the 2021 conference program was a dedicated focus on COVID-19 which addressed the latest scientific findings on the virus and discussed its impact on health in the region.

These were complemented by returning accredited conferences: Laboratory Management, Clinical Chemistry, Clinical Microbiology, Histopathology, Molecular & Genomic Diagnostics, Haematology and Blood Transfusion. A series of medical speciality days have also been scheduled, with experts presenting the latest advancements in specific clinical specialties, including multi-omics, genetics, and stem cells. Medlab Middle East also hosted a range of dedicated online focus days until July 22 to allow participants to continue to do business as well as featured over 180 educational sessions to choose from. The online event platform for both Arab Health and Medlab Middle East was launched on 23 May and will remain available until 22 July.




New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.